HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jarett Feldman Selected Research

ASG-5ME

10/2019A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jarett Feldman Research Topics

Disease

3Prostatic Neoplasms (Prostate Cancer)
10/2019 - 02/2006
1Hypoxia (Hypoxemia)
10/2019
1Constipation
10/2019
1Diarrhea
10/2019
1Exanthema (Rash)
10/2019
1Fatigue
10/2019
1Hyponatremia
10/2019
1Neutropenia
10/2019
1Abdominal Pain (Pain, Abdominal)
10/2019
1Vaccinia
10/2007
1Fowlpox
10/2007
1Disease Progression
02/2006

Drug/Important Bio-Agent (IBA)

2VaccinesIBA
10/2007 - 02/2006
1auristatinIBA
10/2019
1ASG-5MEIBA
10/2019
1Immunoconjugates (Immunoconjugate)IBA
10/2019
1monomethyl auristatin EIBA
10/2019
1TroponinIBA
10/2019
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
10/2007
1Prostate-Specific Antigen (Semenogelase)IBA
10/2007
1Proteins (Proteins, Gene)FDA Link
10/2007
1DNA (Deoxyribonucleic Acid)IBA
10/2007
1Docetaxel (Taxotere)FDA Link
02/2006
1taxaneIBA
02/2006
1AndrogensIBA
02/2006
1Neoplasm Antigens (Tumor Antigens)IBA
02/2006

Therapy/Procedure

1Castration
10/2019
1Drug Therapy (Chemotherapy)
02/2006